| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $475.4M | +13.5% |
| Cost of Revenue | $50.7M | -5.3% |
| Gross Profit | $424.8M | +16.2% |
| R&D Expense | $82.0M | +2.2% |
| SG&A Expense | $37.8M | +2.9% |
| Operating Income | $163.9M | +31.0% |
| Pre-tax Income | $185.2M | +39.1% |
| Income Tax | $37.6M | +85.0% |
| Net Income | $147.6M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $96.8M | -38.8% |
| Accounts Receivable | $101.3M | -5.3% |
| Current Assets | $912.9M | -6.4% |
| Total Assets | $1.08B | -5.1% |
| Current Liabilities | $147.3M | +5.6% |
| Total Liabilities | $178.0M | +4.2% |
| Stockholders' Equity | $901.4M | -6.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $184.1M | +2.5% |
| Capital Expenditures | $147K | -91.4% |
| Investing Cash Flow | $31.2M | +152.0% |
| Financing Cash Flow | -$276.5M | -271.4% |
| Free Cash Flow | $183.9M | +3.4% |
| +30.8% |
| EPS (Basic) | $0.78 | +34.5% |
| EPS (Diluted) | $0.72 | +35.8% |